Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Journal of Neuroimmunology
|
March 10, 2009
Human African trypanosomiasis, chemotherapy and CNS disease
Jean Rodgers
Parasitology
|
December 24, 2009
Trypanosomiasis and the brain
Jean Rodgers
Frontiers in Immunology
|
February 12, 2019
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
Peter G E Kennedy, Jean Rodgers
Plos Neglected Tropical Diseases
|
December 8, 2022
Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse
Samantha Paterson, William Matthew Holmes, Jean Rodgers
Methods (San Diego, Calif.)
|
June 22, 2017
Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis
Jean Rodgers, Barbara Bradley, Peter G E Kennedy
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 31, 2019
Generation of neuroinflammation in human African trypanosomiasis
Jean Rodgers, Israel Steiner, Peter G E Kennedy
Parasitology International
|
July 24, 2007
Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis
Jean Rodgers, Barbara Bradley, Peter G E Kennedy
Scientific Reports
|
May 29, 2023
Application of diffusion weighted multiple boli ASL to a murine model of human African trypanosomiasis
Samantha Paterson, Antoine Vallatos, Jean Rodgers, et al.
Lancet (London, England)
|
May 22, 2002
Sleeping sickness: new drugs from old? [corrected]
Peter G E Kennedy, Maxwell Murray, Frank Jennings, et al.
Plos Neglected Tropical Diseases
|
November 11, 2021
Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains
Paul Montague, Barbara Bradley, Jean Rodgers, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Journal of Neuroimmunology
|
March 10, 2009
Human African trypanosomiasis, chemotherapy and CNS disease
Jean Rodgers
Parasitology
|
December 24, 2009
Trypanosomiasis and the brain
Jean Rodgers
Frontiers in Immunology
|
February 12, 2019
Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
Peter G E Kennedy, Jean Rodgers
Plos Neglected Tropical Diseases
|
December 8, 2022
Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse
Samantha Paterson, William Matthew Holmes, Jean Rodgers
Methods (San Diego, Calif.)
|
June 22, 2017
Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis
Jean Rodgers, Barbara Bradley, Peter G E Kennedy
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 31, 2019
Generation of neuroinflammation in human African trypanosomiasis
Jean Rodgers, Israel Steiner, Peter G E Kennedy
Parasitology International
|
July 24, 2007
Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis
Jean Rodgers, Barbara Bradley, Peter G E Kennedy
Scientific Reports
|
May 29, 2023
Application of diffusion weighted multiple boli ASL to a murine model of human African trypanosomiasis
Samantha Paterson, Antoine Vallatos, Jean Rodgers, et al.
Lancet (London, England)
|
May 22, 2002
Sleeping sickness: new drugs from old? [corrected]
Peter G E Kennedy, Maxwell Murray, Frank Jennings, et al.
Plos Neglected Tropical Diseases
|
November 11, 2021
Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains
Paul Montague, Barbara Bradley, Jean Rodgers, et al.
Page
of 4